UniProtKB/Swiss-Prot O14939: Variant p.Glu632Gly

Phospholipase D2
Gene: PLD2
Feedback?

Variant information Variant position:

632 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glutamate (E) to Glycine (G) at position 632 (E632G, p.Glu632Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and acidic (E) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs17854914 [ dbSNP | Ensembl ]

Sequence information Variant position:

632 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

933 The length of the canonical sequence.
Location on the sequence:

RWSAGTLENSILNAYLHTIR E SQHFLYIENQFFISCSDGRT The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         RWSAGTLENSILNAYLHTIRESQHFLYIENQFFISCSDGRT

Mouse                         RWSAGTLENSILNAYLHTIRESQHFLYIENQFFISCSDGRT

Rat                           RWSAGTLESSILNAYLHTIRESQHFLYIENQFFISCSDGRT

Bovine                        RWSAGTLENSILNAYLHTIRESQHFLYIENQFFISCSDGRT

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 933	Phospholipase D2
Region	441 – 788	Catalytic
Alternative sequence	337 – 933	Missing. In isoform PLD2C.
Helix	621 – 632

Literature citations
Submission
Saqib K.M.; Clark J.M.; Byrd P.J.; Armstrong S.J.; Wakelam M.J.O.;
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PLD2A AND PLD2B); VARIANTS GLY-632 AND SER-821; The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PLD2A); VARIANTS CYS-172; ILE-577 AND GLY-632;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.